These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21120806)

  • 1. Nuclear maspin expression as a good prognostic factor in human epithelial ovarian carcinoma.
    Sopel M; Surowiak P; Berdowska I
    Folia Morphol (Warsz); 2010 Nov; 69(4):204-12. PubMed ID: 21120806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maspin overexpression correlates with increased expression of vascular endothelial growth factors A, C, and D in human ovarian carcinoma.
    Bolat F; Gumurdulu D; Erkanli S; Kayaselcuk F; Zeren H; Ali Vardar M; Kuscu E
    Pathol Res Pract; 2008; 204(6):379-87. PubMed ID: 18343598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous expression of serine protease inhibitor maspin in ovarian cancer.
    Bauerschlag DO; Habermann M; Weimer J; Meinhold-Heerlein I; Hilpert F; Weigel M; Bauer M; Mundhenke C; Jonat W; Maass N; Schem C
    Anticancer Res; 2010 Jul; 30(7):2739-44. PubMed ID: 20683007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paradoxical expression of maspin in gastric carcinomas: correlation with carcinogenesis and progression.
    Yu M; Zheng H; Tsuneyama K; Takahashi H; Nomoto K; Xu H; Takano Y
    Hum Pathol; 2007 Aug; 38(8):1248-55. PubMed ID: 17490717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer.
    Solomon LA; Munkarah AR; Schimp VL; Arabi MH; Morris RT; Nassar H; Ali-Fehmi R
    Gynecol Oncol; 2006 Jun; 101(3):385-9. PubMed ID: 16443262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear expression of maspin is associated with a lower recurrence rate and a longer disease-free interval after surgery for squamous cell carcinoma of the larynx.
    Marioni G; Blandamura S; Giacomelli L; Calgaro N; Segato P; Leo G; Fischetto D; Staffieri A; de Filippis C
    Histopathology; 2005 May; 46(5):576-82. PubMed ID: 15842640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
    Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
    Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MASPIN subcellular localization and expression in oral cavity squamous cell carcinoma.
    Marioni G; Gaio E; Giacomelli L; Bertolin A; D'Alessandro E; Stramare R; Facco E; Staffieri A; Blandamura S
    Eur Arch Otorhinolaryngol; 2008 Jul; 265 Suppl 1():S97-104. PubMed ID: 18236066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maspin expression in epithelial ovarian cancer and associations with poor prognosis: a Gynecologic Oncology Group study.
    ; Secord AA; Lee PS; Darcy KM; Havrilesky LJ; Grace LA; Marks JR; Berchuck A
    Gynecol Oncol; 2006 Jun; 101(3):390-7. PubMed ID: 16551475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shift from cytoplasmic to nuclear maspin expression correlates with shorter overall survival in node-negative colorectal cancer.
    Märkl B; Arnholdt HM; Jähnig H; Schenkirsch G; Herrmann RA; Haude K; Spatz H; Anthuber M; Schlimok G; Oruzio D
    Hum Pathol; 2010 Jul; 41(7):1024-33. PubMed ID: 20334895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear localization of mammary serine protease inhibitor (MASPIN): is its impact on the prognosis in laryngeal carcinoma due to a proapoptotic effect?
    Marioni G; Giacomelli L; D'Alessandro E; Marchese-Ragona R; Staffieri C; Ferraro SM; Staffieri A; Blandamura S
    Am J Otolaryngol; 2008; 29(3):156-62. PubMed ID: 18439947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survivin expression in ovarian carcinoma: correlation with apoptotic markers and prognosis.
    Cohen C; Lohmann CM; Cotsonis G; Lawson D; Santoianni R
    Mod Pathol; 2003 Jun; 16(6):574-83. PubMed ID: 12808063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
    Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
    Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative expression of the human kallikrein gene 9 (KLK9) in ovarian cancer: a new independent and favorable prognostic marker.
    Yousef GM; Kyriakopoulou LG; Scorilas A; Fracchioli S; Ghiringhello B; Zarghooni M; Chang A; Diamandis M; Giardina G; Hartwick WJ; Richiardi G; Massobrio M; Diamandis EP; Katsaros D
    Cancer Res; 2001 Nov; 61(21):7811-8. PubMed ID: 11691797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer.
    Hirai K; Koizumi K; Haraguchi S; Hirata T; Mikami I; Fukushima M; Yamagishi S; Kawashima T; Okada D; Shimizu K; Kawamoto M
    Ann Thorac Surg; 2005 Jan; 79(1):248-53. PubMed ID: 15620951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of Maspin expression is a negative prognostic factor in common salivary gland tumors.
    Schwarz S; Ettl T; Kleinsasser N; Hartmann A; Reichert TE; Driemel O
    Oral Oncol; 2008 Jun; 44(6):563-70. PubMed ID: 17936671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maspin expression in invasive breast cancer: association with other prognostic factors.
    Mohsin SK; Zhang M; Clark GM; Craig Allred D
    J Pathol; 2003 Apr; 199(4):432-5. PubMed ID: 12635133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S; Ilić Forko J; Babić D; Sundov D; Kuret S; Andelinović S
    Croat Med J; 2003 Aug; 44(4):429-34. PubMed ID: 12950146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maspin expression is characteristic for cisplatin-sensitive ovarian cancer cells and for ovarian cancer cases of longer survival rates.
    Surowiak P; Materna V; Drag-Zalesinska M; Wojnar A; Kaplenko I; Spaczyński M; Dietel M; Zabel M; Lage H
    Int J Gynecol Pathol; 2006 Apr; 25(2):131-9. PubMed ID: 16633061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of maspin and its relation to tumor vascularization in epithelian ovarian cancer].
    Ma Y; Peng ZL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):223-7. PubMed ID: 19462894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.